Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.

Laakso A, Vilkman H, Alakare B, Haaparanta M, Bergman J, Solin O, Peurasaari J, Räkköläinen V, Syvälahti E, Hietala J.

Am J Psychiatry. 2000 Feb;157(2):269-71.

PMID:
10671399
2.

Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia.

Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O, Syvälahti E, Hietala J.

Schizophr Res. 2001 Oct 1;52(1-2):115-20.

PMID:
11595398
3.

Prediction of detached personality in healthy subjects by low dopamine transporter binding.

Laakso A, Vilkman H, Kajander J, Bergman J, paranta M, Solin O, Hietala J.

Am J Psychiatry. 2000 Feb;157(2):290-2.

PMID:
10671406
4.

Dopamine transporter change in drug-naive schizophrenia: an imaging study with 99mTc-TRODAT-1.

Hsiao MC, Lin KJ, Liu CY, Tzen KY, Yen TC.

Schizophr Res. 2003 Dec 1;65(1):39-46.

PMID:
14623373
5.

Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study.

Ouchi Y, Kanno T, Okada H, Yoshikawa E, Futatsubashi M, Nobezawa S, Torizuka T, Sakamoto M.

Ann Neurol. 1999 Nov;46(5):723-31.

PMID:
10553989
6.

Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.

Nurmi E, Bergman J, Eskola O, Solin O, Hinkka SM, Sonninen P, Rinne JO.

J Cereb Blood Flow Metab. 2000 Nov;20(11):1604-9.

PMID:
11083235
7.

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T.

World J Biol Psychiatry. 2002 Jul;3(3):133-46. Review.

PMID:
12478878
8.

Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study.

Yang YK, Yu L, Yeh TL, Chiu NT, Chen PS, Lee IH; SPECT study..

Am J Psychiatry. 2004 Aug;161(8):1496-8.

PMID:
15285982
9.

Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.

Ouchi Y, Kanno T, Okada H, Yoshikawa E, Futatsubashi M, Nobezawa S, Torizuka T, Tanaka K.

Brain. 2001 Apr;124(Pt 4):784-92.

PMID:
11287377
10.

Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

Sekine Y, Iyo M, Ouchi Y, Matsunaga T, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Takei N, Mori N.

Am J Psychiatry. 2001 Aug;158(8):1206-14.

PMID:
11481152
11.

[Striatal dopamine transporter density decrease in first episode schizophrenic patients treated with risperidone].

Mateos JJ, Lomeña F, Parellada E, Font M, Fernández E, Pavia J, Prats A, Bernardo M.

Rev Esp Med Nucl. 2006 May-Jun;25(3):159-65. Spanish.

14.

Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.

Nurmi E, Ruottinen HM, Kaasinen V, Bergman J, Haaparanta M, Solin O, Rinne JO.

Ann Neurol. 2000 Jun;47(6):804-8.

PMID:
10852547
15.

Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.

Nurmi E, Bergman J, Eskola O, Solin O, Vahlberg T, Sonninen P, Rinne JO.

Synapse. 2003 Jun 1;48(3):109-15.

PMID:
12645035
16.
17.

Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography.

Tiihonen J, Vilkman H, Räsänen P, Ryynänen OP, Hakko H, Bergman J, Hämäläinen T, Laakso A, Haaparanta-Solin M, Solin O, Kuoppamäki M, Syvälahti E, Hietala J.

Mol Psychiatry. 1998 Mar;3(2):156-61.

PMID:
9577840
19.

Dopamine transporter density in schizophrenic subjects with and without tardive dyskinesia.

Yoder KK, Hutchins GD, Morris ED, Brashear A, Wang C, Shekhar A.

Schizophr Res. 2004 Dec 1;71(2-3):371-5.

PMID:
15474908
20.

Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.

Madras BK, Gracz LM, Fahey MA, Elmaleh D, Meltzer PC, Liang AY, Stopa EG, Babich J, Fischman AJ.

Synapse. 1998 Jun;29(2):116-27.

PMID:
9593102

Supplemental Content

Support Center